Scott Huennekens

We can help you with concept through to commercialization by enabling: • Accelerated speed to market • Controlled development costs • Development risk mitigation • Market viability assessment At every stage, we navigate our clients to realize efficiencies in cost and time with our integrated and comprehensive solutions. Our solution areas include: • Preclinical Services • Regulatory Affairs + Quality Management • Data Management + Analytics • Commercial Strategy + Market Access • Product Design + Engineering • Clinical Development Services For more information, please visit https://www.veranexsolutions.com/

Our Vision: To revolutionize the structural heart market with new material, design and manufacturing technology expanding patient access, improving product performance and significantly reducing costs.

Proximie brings together telepresence, content management, and data insights to enable surgeons to share information and expertise, and improve patient safety.

In the simplest sense, we’re a company that creates solutions. More specifically, we design novel access device technology for neurovascular interventions and unmet clinical needs. Because in the precious seconds that surround a stroke emergency, clinicians need technology that delivers. That’s where we come in.

KARDION ist ein junges und innovatives Medizintechnikunternehmen mit Sitz in Stuttgart. In enger Zusammenarbeit mit Ärzten konzipiert unser Team aus Ingenieuren und Designern überzeugende und wegweisende Medizinsysteme und entwickelt unsere ergonomischen Produkte in technischer Perfektion bis zur Marktreife. Unser ganzheitlicher Ansatz erlaubt es uns, individuelle Nutzerbedürfnisse zu verstehen, technische Anforderungen daraus abzuleiten und komplexe Produktlösungen zuverlässig und einfach nutzbar zu machen. An der Schnittstelle von Technik und Medizin ist es unser Ziel, die Lebensqualität von Herz-Kreislauf-Patienten zu verbessern und Ärzte bestmöglich zu unterstützen. Mit Enthusiasmus, Glaubhaftigkeit und Engagement heben wir den Stand der Medizintechnik auf ein neues Niveau.

Digma aims to harness the power of the small intestine to empower patients and physicians with safe, simple and effective new therapies for type 2 diabetes that dramatically improve their quality of life and long-term health outcomes. We are developing a minimally invasive therapy, Endoscopic Glycemic Management (EGM), that aims to restore the body’s natural ability to control blood glucose levels. The treatment targets the duodenal submucosa which is central to nutrient sensing and metabolic signaling . Our product is compatible with standard gastrointestinal endoscopes and the EGM procedure is being developed so that it can be performed in a standard GI endoscopy suite without requiring additional imaging equipment. Our goal is to provide patients with durable improvement in glycemic control with minimal side effects and without requiring additional daily medical therapy. The EGM procedure is currently being evaluated in clinical studies. To learn more about our clinical program, please contact us.

At Vicarious Surgical we are revolutionizing the field of surgical robotics. We seek to improve the lives of patients, enhance the ability of surgeons, and expand worldwide access to high-quality care through the use of surgical robotics. We have reimagined what is possible by building a human-like surgical robot and combining it with the world’s first virtual-reality surgical camera to allow surgeons to perform minimally-invasive surgery with the ease of an open procedure.

Based near Atlanta, EndoChoice (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists diagnosing and treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 25 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse®).

Endologix LLC is a California-based, global medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease. We have a therapeutic portfolio designed to treat diseases which currently have clinically relevant unmet needs. Our existing products can treat a wide spectrum of vascular disease through abdominal aortic aneurysms to lower limb peripheral vascular disease. We obtain excellent clinical outcomes through meticulous attention to product design, manufacturing, and training, all backed by industry-leading clinical evidence. With a robust pipeline of disruptive technology, our vision is to provide physicians with the best device for each patient; because when it comes to ensuring patient well-being, we are never satisfied with the status quo.

The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the worlds first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The companys initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.

> Bringing precision and passion in everything we do QuidelOrtho stands at the forefront of testing, tracking and disease analysis of health conditions ranging from HIV and hepatitis C to flu, strep and COVID-19. For decades, our precision and accuracy have guided clinicians and lab technicians in the moments that matter most. > Continuing our legacy in diagnostics Our portfolio serves the entire healthcare continuum: from high-volume, high-complexity hospitals and labs to point-of-care, retail and over-the-counter markets. This enables us to continue our legacy of diagnostics in an ever-changing environment where were passionately pursuing the unknown to advance diagnostic science and care. > Raising the bar in diagnostic care Ranked among the world’s largest in vitro diagnostics (IVD) providers, we’re building on more than 120 years of collective experience and innovation. We combine industry-leading expertise in immunoassay and molecular testing with a global footprint in point-of-care settings, clinical labs and transfusion medicine to advance critical diagnostic solutions at scale. > Powering a healthier future for all Inspired by a spirit of service, QuidelOrtho is committed to enhancing the wellbeing of people worldwide and happy in the knowledge we are making a difference. To contact us, please visit https://www.quidelortho.com/global/en/contact-us. For career opportunities, please visit: https://careers.quidelortho.com/global/en. #QuidelOrtho #BetterTogether #PowerUpLabs #HealthierFuture #DiagnosticFrontier #AdvancingScience #TalentNetwork

We can help you with concept through to commercialization by enabling: • Accelerated speed to market • Controlled development costs • Development risk mitigation • Market viability assessment At every stage, we navigate our clients to realize efficiencies in cost and time with our integrated and comprehensive solutions. Our solution areas include: • Preclinical Services • Regulatory Affairs + Quality Management • Data Management + Analytics • Commercial Strategy + Market Access • Product Design + Engineering • Clinical Development Services For more information, please visit https://www.veranexsolutions.com/

Our Vision: To revolutionize the structural heart market with new material, design and manufacturing technology expanding patient access, improving product performance and significantly reducing costs.